Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
229
-
Total 13F shares, excl. options
-
18.8M
-
Shares change
-
+465K
-
Total reported value, excl. options
-
$2.69B
-
Value change
-
+$67.6M
-
Put/Call ratio
-
0.02
-
Number of buys
-
101
-
Number of sells
-
-98
-
Price
-
$143.02
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q2 2016
253 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q2 2016.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 229 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.8M shares
.
Largest 10 shareholders include ATLANTA CAPITAL MANAGEMENT CO L L C (1.77M shares), VANGUARD GROUP INC (1.5M shares), ARIEL INVESTMENTS, LLC (981K shares), ACADIAN ASSET MANAGEMENT LLC (943K shares), BlackRock Fund Advisors (808K shares), LEVIN CAPITAL STRATEGIES, L.P. (796K shares), BlackRock Institutional Trust Company, N.A. (633K shares), STATE STREET CORP (556K shares), WELLS FARGO & COMPANY/MN (543K shares), and NWQ INVESTMENT MANAGEMENT COMPANY, LLC (503K shares).
This table shows the top 229 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.